Российский кардиологический журнал острый коронарный синдром
1. Zoller B, Ji J, Sundquist J, et al. Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden. Eur J Canc. 2012; 48: 121-8.
2. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. J Clin Oncol. 1993; 11 (7): 1208-15.
3. Yusuf SW, Daraban N, Abbasi N, et al. Treatment and outcomes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012; 35: 443-50.
4. Svilaas T, Lefrandt JD, Gietema JA, et al. Long-term arterial complications of chemotherapy in patients with cancer. Thromb Res. 2016; 140: 109-18.
5. Canale ML, Camerini A, Stroppa S, et al. A case of acute myocardial infarction during 5-fluorouracil infusion. J Cardiovasc Med (Hagerstown) 2006; 7: 835-7.
6. Wijesinghe N, Thompson PI, McAlister H. Acute coronary syndrome induced by capecitabine therapy. Heart Lung Circ. 2006; 15: 337-9.
7. Kalapura T, Krishnamurthy M, Reddy CV. Acute myocardial infarction following gemcitabine therapy: a case report. Angiology. 1999; 50: 1021-5.
8. Gemici G, Cinçin A, Degertekin M, et al. Paclitaxel-induced ST-segment elevations. J Clin Cardiol. 2009; 32: 94-6.
9. History of Cancer Confers Worse PCI Outcomes for Acute MI www.medscape.com/viewarticle/871624available 27.11.2016
10. Lin YN, Chang YJ, Chen YH, et al. Nationwide population based cohort study onthe association of acute coronary syndrome in patients with malignancies. Support Care Cancer. 2014; 22(10): 2707-13.
11. Ogawa A, Kanda T, Sugihara S, et al. Risk factors for myocardial infarction in cancer patients. J Med 1995; 26(5-6): 221-33.
12. Sarkiss MG, Yusuf WS, Warneke CL, et al. Impact of Aspirin Therapy in Cancer Patients With Thrombocytopenia and Acute Coronary Syndromes. Cancer. 2007; 109(3): 621-7.
13. Liebman HA. Thrombocytopenia in cancer patients. Thromb Res. 2014; 133: 63-9.
14. Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Williston Park). 2015; 29(4): 282-94.
15. Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. Natl Cancer Inst J. 2006; 98: 1321-30.
16. Lazutina OM, Markova LI, Belaya OL. Myocardial infarction in colon cancer Klin Med (Mosk). 2013; 4: 70-3. Russian (Лазутина О. М., Маркова Л. И., Белая О. Л. Инфаркт миокарда при раке толстой кишки. Клиническая медицина. 2013; 4: 70-3).
17. Yang K, Zhang T, Chen J, et al. Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer. Head Neck. 2012;34(1):127-30.
18. Kantarjian H, Giles F, List A, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer J. 2007; 109(9): 1705-14.
19. Clure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation. 1999; 99: 2892-900.
20. Luzzatto G, Schafer AI. The prethrombotic state in cancer. Semin Oncol. 1990; 17: 147-59.
21. Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation. 2009; 119(18): 2454-62.
22. Boero IJ, Paravati AJ, Triplett DP, et al. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. Int J Radiat Oncol Biol Phys. 2016; 94(4): 700-8.
23. Elting LS, Rubenstein EB, Martin CG, et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol. 2001; 19: 1137-46.
24. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in
25. -year survivors of breast cancer. J Natl Cancer Inst. 2007; 99(5): 365-75.
26. Jagsi R, Griffith KA, Koelling T, et al. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer. 2007; 109(4): 650-7.
27. Hancock SL, Tucker MA, Hoppe RT. Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin’s Disease. JAMA. 1993; 270(16): 1949-55.
28. Schomig K, Ndrepepa G, Mehilli J, et al. Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv. 2007; 70: 359-65.
29. Liang JJ, Sio TT, Slusser JP, et al. Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer. JACC Cardiovasc Interv. 2014; 7(12): 1412-20.
30. Velders MA, Boden H, Hofma SH, et al. Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol. 2013; 112: 1867-72.
31. Hess CN, Roe MT, Clare RM, et al. Relationshipм Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention. J Am Heart Assoc. 2015; 4(7): 1-9.
32. Conti CR. Thrombolytic therapy in thrombocytopenic patients. J Clin Oncol. 1995; 18(6):299-300.
33. Kurisu S, Iwasaki T, Ishibashi K, et al. Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients. Int Cardiol J. 2013; 167: 2335-37.
34. Goloshchapov-Aksenov RS, Lebedev AV, Mirzonov VA. Primary percutaneous coronary angioplasty in patients with acute coronary syndrome and concomitant cancer. Vestn Rentgenol Radiol. 2012; 1: 17-21. Russian (Голощапов-Аксенов Р.С., Лебедев А. В., Мирзонов В. А. Первичная чрескожная коронарная ангиопластика у больных острым коронарным синдромом с сопутствующим онкологическим заболеванием. Вестник рентгенологии и радиологии. 2012; 1: 17-21).
35. Iliescu CA, Grines CL, Herrmann J, et al. SCAI Expert Consensus Statement: Evaluation, Management, and Special Considerations of Cardio-Oncology Patients in the Cardiac Catheterization Laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista). Catheter Cardiovasc Interv. 2016; 87(5): 895-9.
36. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on noncardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35(35): 2383-431.
37. Patel MR, Calhoon JH, Dehmer GJ, et al. ACCF/SCAI/STS/AATS/ AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg. 2012; 143: 780-803.
38. Guddati AK, Joy PS, Kumar G. Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10-year period. J Cancer Res Clin Oncol. 2016; 142: 471-79.
39. Abbott JD, Ahmed HN, Vlachos HA, et al. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2007; 100: 190-5.
40. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur. Heart J. 2016; 37: 2768-801.
41. Krone RJ. Managing coronary artery disease in the cancer patient. Prog Cardiovasc. 2010; 53: 149-56.
42. Staib P, Forsch S, Niedeggen A, et al. Percutaneous coronary intervention in a patient with acute myeloid leukemia. Dtsch Med Wochenschr. 2012; 137(21): 1092-5.
43. Shivaraju A, Patel V, Fonarow GC, et al. Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: Analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database. Am Heart J. 2011; 162: 1062-68.
44. Roe MT, Cyr DD, Eckart D, et al. Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. Eur Heart J. 2016; 37(4): 412-22.
45. Wallentin L, Becker RC, Budaj A, et al, for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11): 1045-57.
Источник
1. . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2017; 00: 1–66. DOI:10.1093/eurheartj/ehx393.
2. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008; 117 (2): 296-329.
3. Pitts R, Daugherty SL, Tang F, et al. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry. Clinical Cardiology 2017; 1-9.
4. Huang FY, Huang BT, Lv WY, et al. The Prognosis of Patients With Nonobstructive Coronary Artery Disease Versus Normal Arteries Determined by Invasive Coronary Angiography or Computed Tomography Coronary Angiography. Medicine 2016; 95 (11): 1-11. https://www.md-journal.com
5. Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. American Heart Journal 2009; 158 (4): 688-94. DOI:10.1016/j.ahj.2009.08.004
6. Syrkin AL, Novikova NA, Terekhin SA. Acute coronary syndrome. M.: Meditcinskoe informatcionnoe agentstvo, 2010. р. 458. (In Russ.) Сыркин А.Л., Новикова Н.А., Терёхин С.А. Острый коронарный синдром. М.: Медицинское информационное агентство, 2010. 458 с. ISBN 978-5-8948-1825-2
7. Erlikh AD, Kharchenko MS, Barbarash OL, et al. The degree of adherence of the implementation of the guidelines on acute coronary syndrome in clinical practice in Russian hospitals and outcomes during hospitalization (data of registry RECORD-2). Kardiologiya 2013; 1: 14–22. (In Russ.) Эрлих А. Д., Харченко М.С., Барбараш О.Л. и др. Степень приверженности к выполнению руководств по лечению острого коронарного синдрома в клинической практике российских стационаров (данные регистра РЕКОРД-2). Кардиология 2013; 1: 14–22.
8. Agewall S, Beltrame JF, Reynolds HR et al. ECS working group position paper on myocardial infarction with non-obstructive coronary arteries. European Heart Journal 2017; 38 (3): 143-53. DOI: 10.1093/eurheartj/ehw149
9. Erlikh AD. Acute coronary syndromes registerstypes, characteristics and place in clinical practice. Vestnik RAMN 2012; 4:30-9. (In Russ.) Эрлих А. Д. Регистры острых коронарных синдромов — их виды, характеристики и место в клинической практике. Вестник РАМН 2012, 4: 30-9.
10. Erlikh AD, Gratsianskii NA on behalf of the RECORD-3 register participants. Russian acute coronary syndrome registry “RECORD-3”. Patients characteristics and treatment before discharge from the hospital. Cardiology 2016; 4 (56): 16-24. (In Russ.) Эрлих А. Д., Грацианский Н.А. от имени участников регистра РЕКОРД-3. Российский регистр острого коронарного синдрома “РЕКОРД-3”. Характеристика пациентов и лечение до выписки из стационара. Кардиология 2016, 4 (56): 16-24. DOI: 10.18565/cardio.2016.4.16-24
11. Erlikh AD, Gratsianskii NA and RECORD register participants. RECORD register. Treatment of patients with acute coronary syndromes in hospitals with and without the ability to perform invasive procedures. Cardiology 2010; 7: 8-14. (In Russ.) Эрлих А. Д., Грацианский Н.А. и участники регистра РЕКОРД. Регистр РЕКОРД. Лечение больных с острыми коронарными синдромами в стационарах, имеющих и не имеющих возможности выполнения инвазивных процедур. Кардиология 2010, 7: 8-14.
12. Mironova TF, Mironov VA, Tyurin AY. The role of the autonomic nervous system in the formation of acute myocardial infarction. Vestnik aritmologii 2005; 39: 53-65. (In Russ.) Миронова Т.Ф., Миронов В.А., Тюрин А.Ю. Роль вегетативной нервной системы в формировании острого инфаркта миокарда. Вестник аритмологии 2005, 39: 53-65.
13. Gomboeva SB, Ryabov VV, Shelkovnikova TA. The case of pseudo-coronary type myocarditis with ST segment elevation on the ECG. Russ J Cardiol 2016; 11 (139): 95-6. (In Russ.) Гомбоева С.Б., Рябов В.В., Шелковникова Т.А. и др. Случай миокардита псевдокоронарного течения с элевацией сегмента ST на ЭКГ. Российский кардиологический журнал 2016, 11 (139): 95-6.
14. Gomboeva SB, Ryabov VV, Shelkovnikova TA, et al. The possibilities of magnetic resonance imaging of the heart in the differential diagnosis of acute coronary syndrome in patients with non-obstructive coronary artery atherosclerosis. Siberian Medical Journal (Tomsk) 2017; 32 (1): 39-46. (In Russ.) Гомбоева С.Б., Рябов В.В., Шелковникова Т.А. и др. Возможности магнитно-резонансной томографии сердца в дифференциальной диагностике острого коронарного синдрома у пациентов с необструктивным атеросклерозом коронарных артерий. Сибирский медицинский журнал (г. Томск) 2017, 32 (1): 39-46.
Источник
1. Бойцов С.А., Шальнова С.А., Деев А.Д. Смертность от сердечно-сосудистых заболеваний в Российской Федерации и возможные механизмы ее изменения. Журнал неврологии и психиатрии им. CC Корсакова. 2018;118(8):98-103. doi: 10.17116/jnevro201811808198.
2. Демографический ежегодник России. 2017: Стат. сб. Росстат. М., 2017. с. 263. ISBN 978-5-89476-447-4.
3. Wilkins E, Wilson L, Wickramasinghe K, et al. European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels. https://www.ehnheart.org/images/CVD-statistics-report-August-2017 (05 Feb 2019).
4. Концевая А.В., Драпкина О.М., Баланова Ю.А., и др. Экономический ущерб сердечно-сосудистых заболеваний в Российской Федерации в 2016 году. Рациональная Фармакотерапия в Кардиологии. 2018;14(2):156-66. doi:10.20996/1819-6446-2018-14-2-156-166.
5. Cагайдак О.В., Ощепкова Е.В., Попова Ю.В., и др. Подходы к оптимизации временных показателей оказания медицинской помощи больным с острым коронарным синдромом в системе Федерального регистра острого коронарного синдрома и мониторинга Минздрава России. Кардиологический вестник. 2017;4:82-87.
6. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
7. Ганюков В.И., Протопопов А.В., Башкирева А.Л., и др. Европейская инициатива “Stent for Life” в России. РКЖ. 2016;(6):68-72. doi: 10.15829/1560-4071-2016-6-68-72.
8. Park Y, Kang G, Song B, et al. Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction. J Korean Med Sci. 2012;27(8):864-9. doi: 10.3346/jkms.2012.27.8.864.
9. Mackay M, Ratner P, Nguyen M, et al. Inconsistent measurement of acute coronary syndrome patients’ pre-hospital delay in research: a review of the literature. Eur J Cardiovasc Nurs. 2014;13(6):483-93. doi:10.1177/1474515114524866.
10. Saczynski J, Yarzebski J, Lessard D, et al. Trends in Pre-hospital Delay in Patients with Acute Myocardial Infarction (From The Worcester Heart Attack Study). Am J Cardiol. 2008;102(12):1589–1594. doi:10.1016/j.amjcard.2008.07.056.
11. O’Donnell S, McKee G, Mooney M, et al. Slow-onset and fast-onset symptom presentations in acute coronary syndrome (ACS): new perspectives on prehospital delay in patients with ACS. J Emerg Med. 2014;46(4):507-15. doi: 10.1016/j.jemermed.2013.08.038.
12. McKee G, Mooney M, O’Donnell S, et al. Multivariate analysis of predictors of pre-hospital delay in acute coronary syndrome. Int J Cardiol. 2013;168(3):2706-13. doi: 10.1016/j.ijcard.2013.03.022.
13. Nilsson G, Mooe T, Söderström L, et al. Pre-hospital delay in patients with first time myocardial infarction: an observational study in a northern Swedish population. BMC Cardiovasc Disord. 2016;16:93. doi:10.1186/s12872-016-0271-x.
14. Kalla K, Christ G, Karnik R, et al. Implementation of Guidelines Improves the Standard of Care. The Viennese Registry on Reperfusion Strategiesin ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation. 2006;113:2398-2405.
15. Goldberg R, Spencer F, Fox K, et al. Prehospital delay in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009;103:598–603. doi: 10.1016/j.amjcard.2008.10.038.
16. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27(19):2285-93. doi: 10.1093/eurheartj/ehl196.
17. Приказ Министерства здравоохранения РФ от 27 февраля 2016 г. № 132н «О Требованиях к размещению медицинских организаций государственной системы здравоохранения и муниципальной системы здравоохранения исходя из потребностей населения”. Министерство здравоохранения Российской Федерации: URL: www.rosminzdrav.ru. (24 Apr 2019).
18. O’Gara P, Kushner F, Ascheim D, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):362-425. doi: 10.1161/CIR.0b013e3182742cf6.
19. Sullivan A, Beshansky J, Ruthazer R, et al. Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study. Circ Cardiovasc Qual Outcomes. 2014;7(1):86-94. doi: 10.1161/CIRCOUTCOMES.113.000396.
20. ACCESS Investigators. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies. Am Heart J. 2011;162(5):852-859. doi: 0.1016/j.ahj.2011.07.029.
21. Xavier D, Pais P, Devereaux P, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371(9622):1435-42. doi: 10.1016/S0140-6736(08)60623-6.
22. Эрлих А.Д., Грацианский Н.А. от имени участников регистра РЕКОРД-3. Российский регистр острого коронарного синдрома РЕКОРД-3. Характеристика пациентов и лечение до выписки из стационара. Кардиология. 2016;4:16-24. doi: 10.18565/cardio.2016.4.16-24.
23. Булахова И.Ю. Влияние позднего обращения за медицинской помощью больных инфарктом миокарда на своевременность госпитализации и течение заболевания. Клиническая медицина. 2009;4:63-67.
24. Гинзбург М.Л., Кутишенко Н.П., Марцевич С.Ю., и др. Анализ факторов, влияющих на сроки поступления в стационар пациентов с острым коронарным синдромом (по данным исследования ЛИС — Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Рациональная Фармакотерапия в Кардиологии. 2012;8(2):141-148. doi: 10.20996/1819-6446-2012-8-2-141-148.
25. Шевченко И.И., Эрлих А.Д., Исламов Р.Р., и др. Сравнение данных регистров острых коронарных синдромов РЕКОРД и РЕКОРД-2: лечение и его исходы в стационарах, не имеющих возможности выполнения инвазивных коронарных процедур. Кардиология. 2013;8:4-10.
26. Косягина Д.Д., Завырылина П.Н., Седых Д.Ю., и др. Факторы, ассоциированные с поздним обращением за медицинской помощью при инфаркте миокарда. Комплексные проблемы сердечно-сосудистых заболеваний. 2017;(3):104-112. doi: 10.17802/2306-1278-2017-6-3-104-112.
27. Perkins-Porras L, Whitehead D, Strike P, et al. Pre-hospital delay in patients with acute coronary syndrome: factors associated with patient decision time and home-to-hospital delay. Eur J Cardiovasc Nurs. 2009;8(1):26-33. doi:10.1016/j.ejcnurse.2008.05.001.
28. Nguyen H, Saczynski J, Gore J, et al. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2010;3:82–92. doi: 10.1161/CIRCOUTCOMES.109.884361.
29. Zhang Z, Fang J, Gillespie C, et al. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012;109(8):1097-103. doi: 10.1016/j.amjcard.2011.12.001.
30. Ефремова О.А., Семикопенко И.С., Рыбасова Т.А., и др. Эпидемиологическая характеристика атипичных форм инфаркта миокарда по Белгородской области. Научные ведомости БелГУ. Медицина. Фармация. 2015;22(32):104-106.
31. Ladwig K, Fang X, Wolf K, et al. Comparison of Delay Times Between Symptom Onset of an Acute ST-elevation Myocardial Infarction and Hospital Arrival in Men and Women <65 Years Versus ≥65 Years of Age.: Findings From the Multicenter Munich Examination of Delay in Patients Experiencing Acute Myocardial Infarction (MEDEA) Study. Am J Cardiol. 2017;120(12):2128-2134. doi:10.1016/j.amjcard.2017.09.005
32. Moser D, McKinley S, Dracup K, et al. Gender differences in reasons patients delay in seeking treatment for acute myocardial infarction symptoms. Patient Educ Couns. 2005;56:45–54.
33. Ting H, Bradley E, Wang Y, et al. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med. 2008;168(9):959-68. doi: 10.1001/archinte.168.9.959.
34. Lovlien M, Schei B, Hole T. Prehospital delay, contributing aspects and responses to symptoms among Norwegian women and men with first time acute myocardial infarction. Eur J Cardiovasc Nurs. 2007; 6(4):308-13. doi:10.1016/j.ejcnurse.2007.03.002.
35. Fathi M, Rahiminiya A, Zare M, et al. Risk factors of delayed pre-hospital treatment seeking in patients with acute coronary syndrome: A prospective study. Turk J Emerg Med. 2016;15(4):163-7. doi:10.1016/j.tjem.2015.06.001.
36. Mozer D, Kimble L, Alberts M, et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Council on cardiovascular nursing and stroke council. Circulation. 2006;114:168-182.
37. Xie L, Huang S-F, Hu Y-Z. Factors influencing pre-hospital patient delay in patients with acute myocardial infarction. Chinese Nursing Research. 2015;2:75-79. doi:10.1016/j.cnre.2015.04.002.
38. Bunde J, Martin R. Depression and prehospital delay in the context of myocardial infarction. Psychosom Med. 2006;68:51–7. doi:10.1097/01.psy.0000195724.58085.f0.
39. Thuresson M, Jarlöv M, Lindahl B, et al. Thoughts, actions, and factors associated with prehospital delay in patients with acute coronary syndrome. Heart Lung. 2007;36(6):398-409. doi: 10.1016/j.hrtlng.2007.02.001.
40. Dracup K, McKinley S, Moser D. Australian patients’ delay in response toheart attack symptoms. Med J Aust. 1997;166(5):233-6.
41. Farshidi H, Rahimi S, Abdi A, et al. Factors Associated With Pre-hospital Delay in Patients With Acute Myocardial Infarction. Iran Red Crescent Med J. 2013;15(4):312-6. doi: 10.5812/ircmj.2367.
42. Концевая А.В., Мырзаматова А.О., Каширин А.К. Факторы риска сердечно-сосудистых заболеваний среди жителей сельской местности по данным эпидемиологических исследований: обзор литературы. Кардиоваскулярная терапия и профилактика. 2016;15(6):66-71. doi: 10.15829/1728-8800-2016-6-66-71.
43. Timonin S, Kontsevaya A, McKee M, et al. Reducing geographic inequalities inaccess times for acute treatment of myocardial infarction in a large country: the example of Russia. Int J Epidemiol. 2018;47(5):1594-1602. doi:10.1093/ije/dyy146.
44. Dracup K, McKinley S, Riegel B, et al. A randomized clinical trial to reduce patient prehospital delay to treatment in acute coronary syndrome. Circ Cardiovasc Qual Outcomes. 2009;2(6):524–532. doi:10.1161/CIRCOUTCOMES.109.852608.
45. Wright R, Kopecky S, Timm M, et al. Impact of community-based education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project. Fam Pract. 2001;18(5):537-9.
46. Strömbäck U, Engström Å, Lundqvist R, et al. The second myocardial infarction: Is there any difference in symptoms and prehospital delay compared to the first myocardial infarction? Eur J Cardiovasc Nurs. 2018 ;17(7):652-659. doi: 10.1177/1474515118777391.
Источник